User:Mr. Ibrahem/Pegaptanib

Pegaptanib, sold under the brand name Macugen, is a medication that was used to treat wet age-related macular degeneration (AMD). It was used by injection into the eye.

Common side effects include blurry vision, cataracts, conjunctival bleeding, eye pain, and increased intraocular pressure. Other side effects may include anaphylaxis and endophthalmitis. It works by blocking vascular endothelial growth factor (VEGF).

Pegaptanib was approved for medical use in the United States in 2004. While it was approved in Europe in 2006, this approval was subsequently withdrawn. In the United States a vial of 0.3 mg costs about 780 USD. As of 2016 it is no longer available in the USA.